| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-38 |
| filingDate |
1993-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_587747325f78dc0dae417c281ae96303
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a66739a542a1acabcf4df5dca66d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b26c3fb1750b2f4422c0961dd799046 |
| publicationDate |
1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H0739388-A |
| titleOfInvention |
Method for producing heparin-binding growth factor |
| abstract |
(57) [Summary] [Structure] A cell line transformed by introducing a gene encoding a heparin-binding growth factor such as hepatocyte growth factor (HGF) in the presence of a sulfated polysaccharide or an agonist thereof is described. After culturing, heparin-binding growth factor is collected from the culture solution. [Effect] According to the method of the present invention, it is possible to increase the amount of heparin-binding growth factor produced and recovered by several times as compared with the conventional method, and it is expected that the factor will be widely used in the medical field. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7955833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009521232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906648-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994612-B2 |
| priorityDate |
1993-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |